Cargando…

High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)

We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Soumah, Abou Aissata, Diallo, Mamadou Saliou Kalifa, Guichet, Emilande, Maman, David, Thaurignac, Guillaume, Keita, Alpha Kabinet, Bouillin, Julie, Diallo, Haby, Pelloquin, Raphael, Ayouba, Ahidjo, Kpamou, Cece, Peeters, Martine, Delaporte, Eric, Etard, Jean-Francois, Toure, Abdoulaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992319/
https://www.ncbi.nlm.nih.gov/pubmed/35493112
http://dx.doi.org/10.1093/ofid/ofac152
_version_ 1784683708680241152
author Soumah, Abou Aissata
Diallo, Mamadou Saliou Kalifa
Guichet, Emilande
Maman, David
Thaurignac, Guillaume
Keita, Alpha Kabinet
Bouillin, Julie
Diallo, Haby
Pelloquin, Raphael
Ayouba, Ahidjo
Kpamou, Cece
Peeters, Martine
Delaporte, Eric
Etard, Jean-Francois
Toure, Abdoulaye
author_facet Soumah, Abou Aissata
Diallo, Mamadou Saliou Kalifa
Guichet, Emilande
Maman, David
Thaurignac, Guillaume
Keita, Alpha Kabinet
Bouillin, Julie
Diallo, Haby
Pelloquin, Raphael
Ayouba, Ahidjo
Kpamou, Cece
Peeters, Martine
Delaporte, Eric
Etard, Jean-Francois
Toure, Abdoulaye
author_sort Soumah, Abou Aissata
collection PubMed
description We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in December 2020 during the first survey (S1) to 28.9% (95% CI, 25.6%–32.4%) in March/April 2021 (S2), then to 42.4% (95% CI, 39.5%–45.3%) in June 2021 (S3). This significant overall trend of increasing seroprevalence (P < .0001) was also significant in every age class, illustrating a sustained transmission within the whole community. These data may contribute to defining cost-effective response strategies.
format Online
Article
Text
id pubmed-8992319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89923192022-04-12 High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) Soumah, Abou Aissata Diallo, Mamadou Saliou Kalifa Guichet, Emilande Maman, David Thaurignac, Guillaume Keita, Alpha Kabinet Bouillin, Julie Diallo, Haby Pelloquin, Raphael Ayouba, Ahidjo Kpamou, Cece Peeters, Martine Delaporte, Eric Etard, Jean-Francois Toure, Abdoulaye Open Forum Infect Dis Major Article We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in December 2020 during the first survey (S1) to 28.9% (95% CI, 25.6%–32.4%) in March/April 2021 (S2), then to 42.4% (95% CI, 39.5%–45.3%) in June 2021 (S3). This significant overall trend of increasing seroprevalence (P < .0001) was also significant in every age class, illustrating a sustained transmission within the whole community. These data may contribute to defining cost-effective response strategies. Oxford University Press 2022-03-23 /pmc/articles/PMC8992319/ /pubmed/35493112 http://dx.doi.org/10.1093/ofid/ofac152 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Soumah, Abou Aissata
Diallo, Mamadou Saliou Kalifa
Guichet, Emilande
Maman, David
Thaurignac, Guillaume
Keita, Alpha Kabinet
Bouillin, Julie
Diallo, Haby
Pelloquin, Raphael
Ayouba, Ahidjo
Kpamou, Cece
Peeters, Martine
Delaporte, Eric
Etard, Jean-Francois
Toure, Abdoulaye
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title_full High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title_fullStr High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title_full_unstemmed High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title_short High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
title_sort high and rapid increase in seroprevalence for sars-cov-2 in conakry, guinea: results from 3 successive cross-sectional surveys (anrs cov16-ariacov)
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992319/
https://www.ncbi.nlm.nih.gov/pubmed/35493112
http://dx.doi.org/10.1093/ofid/ofac152
work_keys_str_mv AT soumahabouaissata highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT diallomamadousalioukalifa highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT guichetemilande highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT mamandavid highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT thaurignacguillaume highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT keitaalphakabinet highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT bouillinjulie highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT diallohaby highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT pelloquinraphael highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT ayoubaahidjo highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT kpamoucece highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT peetersmartine highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT delaporteeric highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT etardjeanfrancois highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov
AT toureabdoulaye highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov